BEtablocker Treatment After Acute Myocardial Infarction in Patients Without Reduced Left Ventricular Systolic Function (BETAMI)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03646357 |
|
Recruitment Status :
Active, not recruiting
First Posted : August 24, 2018
Last Update Posted : March 1, 2024
|
Sponsor:
Oslo University Hospital
Collaborators:
Vestre Viken Hospital Trust
The Hospital of Vestfold
University of Oslo
Helse Stavanger HF
Haukeland University Hospital
St. Olavs Hospital
University Hospital of North Norway
Sorlandet Hospital HF
Norwegian University of Science and Technology
Sykehuset Innlandet HF
Nordlandssykehuset HF
Lovisenberg Diakonale Hospital
Diakonhjemmet Hospital
Ostfold Hospital Trust
Information provided by (Responsible Party):
Dan Atar, Oslo University Hospital
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Estimated Primary Completion Date : | December 10, 2024 |
| Estimated Study Completion Date : | December 10, 2034 |